Stay updated on Nivolumab and Metformin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Metformin in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from `v3.7.2` to `v3.8.0`.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH announcement about using “Super Intelligence” in place of “Artificial Intelligence” appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check17 days agoChange DetectedThe ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating the page is not accessible and shows the standard error screen.SummaryDifference21%

- Check66 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, signaling a newer release of the page. This appears to be a system-level update rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Metformin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.